Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADAG Adagene

Pre-Mkt 10-01 05:27:16 EDT

3.20

-0.01

-0.31%

High3.35	Low3.00	Vol254.32K
Open3.18	D1 Closing3.21	Amplitude10.90%
Mkt Cap214.86M	Tradable Cap135.04M	Total Shares67.14M
T/O822.54K	T/O Rate0.60%	Tradable Shares42.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADAG","market":"US","secType":"STK","nameCN":"Adagene","latestPrice":3.2,"timestamp":1790798400000,"preClose":3.21,"halted":0,"volume":254321,"delay":0,"changeRate":-0.0031152647975077217,"floatShares":42200600,"shares":67143300,"eps":-0.3773,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"10-01 05:27:16 EDT","open":3.18,"high":3.35,"low":3,"amount":822544.6880775001,"amplitude":0.109034,"askPrice":3.52,"askSize":100,"bidPrice":2.62,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.3773,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":1.25,"listingDate":1612846800000,"exchange":"NASDAQ","adjPreClose":3.2,"postHourTrading":{"tag":"盘后","latestPrice":3.2,"preClose":3.2,"latestTime":"19:30 EDT","volume":559,"amount":1791.3,"timestamp":1790811002329,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7286224412283673},"requestUrl":"/m/hq/s/ADAG/wiki","defaultTab":"wiki","newsList":[{"id":"2671168852","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671168852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671168852?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679012,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF), Adagene (ADAG) and Inven...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU2539964713.USD","BK4581","RHHVF","ADAG","IVA","BK4588","LU0128526141.USD","LU2293690082.USD","HCSG","BK4007","XLV","LU1046234339.USD","XBI","LU2293690249.USD","BK4137","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670928422","title":"Adagene Announces Finance Executive Resignation Effective September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670928422","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670928422?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:01","pubTimestamp":1790370067,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Adagene ( ($ADAG) ). On September 30, 2026, Adagene Inc. announced that Ms. Chunfang (Vicky) Gu resigned from h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-announces-finance-executive-resignation-effective-september-30-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-announces-finance-executive-resignation-effective-september-30-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142557","title":"Adagene to Begin Phase 1 Study of Adg138 for Advanced Solid Tumors in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142557","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142557?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:52","pubTimestamp":1790081527,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Adagene Inc. <978y.F>::*ADAGENE ANNOUNCES NMPA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR ADG138, A NOVEL HER2XCD3 DOUBLE-MASKED BISPECIFIC T-CELL ENGAGER*ADAGENE - TO B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcvMZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144262","title":"Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144262","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144262?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080070,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has issued an announcement. Adagene Inc., a platform-driven, clinical-stage biotechnology company listed on Nasdaq, specializes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XT","RSPH","DARP","IEIH","BK4585","BK4588","LCLG","IBB","LNGR","BBC","ADAG","NQmain","SYNB","JDOC","BBP","FHLC","BK4139","FWD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142880","title":"Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142880","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142880?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"Phase 1 study with ADG138 for patients with advanced solid tumors is expected to begin in China in the fourth quarter of 2026 ADG138 is a double-masked T-cell engager, applying Adagene’s proprietary S","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366259/0/en/adagene-announces-nmpa-clearance-of-investigational-new-drug-application-for-adg138-a-novel-her2xcd3-double-masked-bispecific-t-cell-engager.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0456854461.SGD","MSS","LU0266512127.USD","BK4113","IND","CRC","BK4213","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668891917","title":"Adagene CEO Makes Bold Insider Move With Fresh Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2668891917","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668891917?lang=en_us&edition=fundamental","pubTime":"2026-09-18 10:05","pubTimestamp":1789697128,"startTime":"0","endTime":"0","summary":"New insider activity at Adagene ( ($ADAG) ) has taken place on September 17, 2026. Adagene’s CEO, Peter Luo, has shown confidence in the company by...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/adagene-ceo-makes-bold-insider-move-with-fresh-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/adagene-ceo-makes-bold-insider-move-with-fresh-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668652349","title":"Adagene CEO Peter Luo Buys 20,290 ADS Worth $63,974.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2668652349","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668652349?lang=en_us&edition=fundamental","pubTime":"2026-09-17 18:12","pubTimestamp":1789639934,"startTime":"0","endTime":"0","summary":"Adagene CEO Peter Luo buys 20,290 ADS worth $63,974.40Adagene CEO Peter Luo bought 20,290 American Depositary Shares at an average price of USD 3.15.Directly held ADS position rose to 88,535 shares fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL72yhQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adagene CEO Peter Luo Buys 20,290 ADS Worth $63,974.40","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668557","title":"Adagene Price Target Maintained with a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668557?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:03","pubTimestamp":1789383780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADAG/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666216595","title":"Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216595?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:40","pubTimestamp":1789126806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adagene (ADAG), AbbVie (ABBV) and Definium Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","LU1732799900.SGD","LU0708994859.HKD","JDOC","LU0820561818.USD","LU2023251221.USD","LU1037948897.HKD","IE0004445239.USD","LU1074936037.SGD","LU0689626769.HKD","LU0661504455.SGD","XBI","XLV","LU1934455863.HKD","LU0795875169.SGD","IE0002270589.USD","LU2347655073.USD","MEDX","IE00B2B36J28.USD","LU0417517546.SGD","PPH","LU2433249047.HKD","RXL","VHT","IXJ","LU1983299246.USD","LU1061106388.HKD","PJP","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0009355771.USD","LU0726765562.USD","LU0098860793.USD","HCSG","LU1057294990.SGD","FHLC","GLAM","TRUH","LU0289739699.SGD","LU2125909247.SGD","LABU","IYH","IE00B42XCP33.USD","LU1496350502.SGD","SG9999011175.SGD","FTXH","AGNG","ABBV","LU1923622614.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666594701","title":"Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2666594701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666594701?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:05","pubTimestamp":1789052723,"startTime":"0","endTime":"0","summary":"Charles Zhu, an analyst from LifeSci Capital, maintained the Buy rating on Adagene. The associated price target remains the same with $8.00. Charle...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/adagenes-platform-partnerships-and-muzastotug-catalysts-support-buy-rating-price-target-unchanged-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/adagenes-platform-partnerships-and-muzastotug-catalysts-support-buy-rating-price-target-unchanged-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666759800","title":"Adagene, Third Arc Bio Expand SAFEbody Masked CD3 T-Cell Engager Collaboration with First Lead Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=2666759800","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666759800?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:04","pubTimestamp":1789041845,"startTime":"0","endTime":"0","summary":"Adagene, Third Arc Bio expand SAFEbody masked CD3 T-cell engager collaboration with first lead pickAdagene broadened its strategic licensing collaboration with Third Arc Bio after Third Arc selected t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbVgK8M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666359817","title":"Adagene Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666359817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666359817?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:57","pubTimestamp":1789041420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADAG/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956773","title":"Chardan Initiates Adagene at Buy With $9 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956773","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666956773?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:59","pubTimestamp":1789037991,"startTime":"0","endTime":"0","summary":"Adagene (ADAG) has an average rating of buy and mean price target of $10.49, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666256766","title":"Adagene initiated with a Buy at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666256766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666256766?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:35","pubTimestamp":1789036521,"startTime":"0","endTime":"0","summary":"Chardan initiated coverage of Adagene (ADAG) with a Buy rating and $9 price target Adagene is a clinical stage company developing its lead asset, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adagene-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adagene-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666953663","title":"Adagene Receives Milestone Payment From Exelixis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666953663?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:42","pubTimestamp":1788961358,"startTime":"0","endTime":"0","summary":"Adagene  said Wednesday that a preclinical milestone for drug candidate XB404 triggered a $2 million payment from licensing partner Exelixis .The selection of candidates for a separate antibody-drug program generated an additional payment, the company said.The company remains eligible for future development and commercialization milestones along with royalties on net product sales, Adagene said.Shares of Adagene were down 2% in Wednesday trading.Price: 3.41, Change: -0.08, Percent Change: -2.29","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4139","ADAG","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533954","title":"Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533954","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533954?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:34","pubTimestamp":1788957298,"startTime":"0","endTime":"0","summary":"An update from Adagene ( ($ADAG) ) is now available. On September 9, 2026, Adagene Inc. reported achieving a preclinical milestone in its collabora...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-secures-milestone-payments-in-exelixis-safebody-adc-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-secures-milestone-payments-in-exelixis-safebody-adc-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","ADAG","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666651538","title":"Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666651538","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666651538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955414,"startTime":"0","endTime":"0","summary":"Adagene receives USD 2 million Exelixis milestone payment for SAFEbody ADC programAdagene reported a USD 2 million milestone payment from Exelixis tied to a preclinical milestone for SAFEbody ADC cand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3Bn9SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4585","BK4139","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","BK4532","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","ADAG","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","EXEL","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666385795","title":"Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666385795","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666385795?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:02","pubTimestamp":1788955351,"startTime":"0","endTime":"0","summary":"Adagene hits preclinical milestone for Exelixis-partnered XB404 SAFEbody ADC, triggers $2 million paymentAdagene hit a preclinical milestone for Exelixis-partnered XB404, a SAFEbody-masked ADC targeti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL4Qc0yx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","ADAG","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533137","title":"Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533137","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533137?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and develop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358564/0/en/adagene-achieves-milestone-in-collaboration-with-exelixis-for-advancement-of-safebody-antibody-drug-conjugate-candidates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","MSS","NETL","CRC","BK4080","BK4532","LU0266512127.USD","BK4113","LU0456854461.SGD","BK4213","ADC","BK4139","ADAG","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339138","title":"Adagene Posts Investor Presentation on Masked Anti-CTLA-4 Program Adg126","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339138?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:32","pubTimestamp":1788521564,"startTime":"0","endTime":"0","summary":"Adagene posts investor presentation on masked anti-CTLA-4 program ADG126Adagene published a medical research presentation outlining clinical progress for ADG126 (muzastotug), a masked anti-CTLA-4 anti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL4mkGLm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0774},{"period":"1month","weight":-0.0883},{"period":"3month","weight":-0.2841},{"period":"6month","weight":-0.198},{"period":"1year","weight":0.608},{"period":"ytd","weight":0.6931}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Their platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity. These features enable their novel drug discovery strategy to advance from lead identification through vigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings. They have pioneered a dynamic interface design to harness the conformational diversity of antibodies, which enlarges epitope sampling of a given drug target for differentiated therapeutic antibody development. Their platform is designed to enable the rapid development of precision immunotherapy candidates, through the identification of predictive biomarkers for patient stratification and preselection.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.330237},{"month":2,"riseRate":0.4,"avgChangeRate":-0.074707},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.132812},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.082401},{"month":5,"riseRate":0.666667,"avgChangeRate":0.056675},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.004737},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062128},{"month":8,"riseRate":0.5,"avgChangeRate":0.001506},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.078426},{"month":10,"riseRate":0.2,"avgChangeRate":-0.090108},{"month":11,"riseRate":0.6,"avgChangeRate":0.034268},{"month":12,"riseRate":0.4,"avgChangeRate":0.020923}],"exchange":"NASDAQ","name":"Adagene","nameEN":"Adagene","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adagene,ADAG,Adagene股票,Adagene股票老虎,Adagene股票老虎国际,Adagene行情,Adagene股票行情,Adagene股价,Adagene股市,Adagene股票价格,Adagene股票交易,Adagene股票购买,Adagene股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction